McMillan Office’s MetLife MET Stock Holding History

McMillan Office’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.4K	Hold	300	–	–	﹤0.01%	341
2026 Q1	$21.2K	Hold	300	–	–	﹤0.01%	337
2025 Q4	$23.7K	Buy	+300	New	+$23.7K	﹤0.01%	330

Other funds holding MET

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

McMillan Office's MET Position: Q2 2026 in Review

McMillan Office held its MetLife (MET) position steady in Q2 2026 at 300 shares worth $25.4K. The position accounts for ﹤0.01% of the portfolio, ranked #341.

McMillan Office first reported a position in MET in Q4 2025 and has held it in 3 quarters since. 1,450 funds tracked by Wall St. Rank hold MET as of Q2 2026.

McMillan Office held 300 shares of MetLife worth $25.4K as of Q2 2026.
McMillan Office left its MetLife share count unchanged in Q2 2026.
MetLife made up ﹤0.01% of McMillan Office's portfolio in Q2 2026, its #341 holding.
McMillan Office first reported a position in MetLife in Q4 2025 and has held it in 3 quarters since.
1,450 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on McMillan Office's 13F filing for Q2 2026, filed 13 Aug 2026.